Oruka Therapeutics(GB:0H79)
GB:0H79
Oruka Therapeutics hedge funds
Oruka Therapeutics (0H79) Hedge Fund Trading Activity
0 Followers
Trend: ▲ Hedge Funds Increased Holdings by 350.2K Shares Last Quarter
Hedge Fund Holdings in 0H79
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Blackstone Inc. | Added | 37.04% | $35,323,516 | 0.14% | |||
| Perceptive Advisors LLC | Added | 16.44% | $44,752,745 | 0.80% | |||
| Woodline Partners LP | Added | 0.04% | $17,414,701 | 0.07% | |||
| Fairmount Funds Management Llc | Not Changed | 0.00% | $112,306,491 | 8.55% | |||
| Viking Global Investors LP | Not Changed | 0.00% | $80,827,373 | 0.21% |
FAQ
Which hedge funds hold Oruka Therapeutics?
The hedge funds that hold the most shares in Oruka Therapeutics are Peter Harwin, Andreas Halvorsen and Joseph Edelman.
Are hedge funds buying or selling GB:0H79?
In the last quarter hedge funds have Increased their holdings in Oruka Therapeutics by 350.2K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Oruka Therapeutics stock?
Warren Buffet currently does not own shares in Oruka Therapeutics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here

